Critics say a legal maneuver by one of the world's wealthiest corporations could set a precedent, allowing non-bankrupt companies and rich individuals to avoid liability for wrongdoing.
Idaho Gov. Brad Little and Attorney General Lawrence Wasden say it's the second-largest consumer settlement in state history.
Companies that aren't bankrupt are using controversial maneuvers in U.S. bankruptcy court to block tens of thousands of suits. A woman suing Johnson & Johnson died while her case was in legal limbo.
A federal judge has allowed a Johnson & Johnson spinoff to proceed with a controversial bankruptcy, despite complaints from thousands who say they were harmed by the company's baby powder.
Does a booster shot mean that you can go back to ... normal? Or is there still a newish kind of normal to face?
The agency acted after an independent panel of scientists strongly supported the move. Kids could start getting vaccinated within the week.
CDC Director Rochelle Walensky also endorsed a mix-and-match approach to boosters that would be flexible for patients and health care providers.
Johnson & Johnson spun off liabilities — including roughly 38,000 lawsuits — linked to claims of asbestos contamination in its baby powder to a new firm, which then declared bankruptcy.
Boosters are available for higher-risk people who got the Pfizer vaccine. But what about people who got the one-shot Johnson & Johnson? Some doctors say they need an extra shot even more urgently.
Johnson & Johnson shared data from its Phase 3 trial of the company's booster shot on Tuesday. The data showed a booster shot at six months provided a 12-fold increase in antibodies.
Johnson & Johnson said that when it gave study participants a second jab after six months, their antibody levels were nine times higher than they were 28 days after a first dose of the COVID vaccine.
The complaint claims the New Jersey-based company made Black women a "central part" of its business strategy but failed to warn them about the potential dangers of the powder products it was selling.
House subcommittee members questioned why Emergent BioSoultions awarded bonuses to executives despite quality problems than hindered production of Johnson & Johnson's COVID-19 vaccine.
The report on Emergent BioSolutions' Baltimore factory found an array of problems, from peeling paint to inadequate measures to prevent cross-contamination. Manufacturing at the facility is on hold.
Government health officials are recommending a "pause" in vaccinations with the Johnson & Johnson COVID-19 vaccine. We're answering your questions as we learn more.